‘Pharma Bro’ Martin Shkreli Begins Securities Fraud Trial
LISTEN TO TLR’S LATEST PODCAST: By Andrea Vacchiano Martin Shkreli, the former CEO of Turing Pharmaceuticals who gained notoriety for raising the cost of the AIDS drug Daraprim from $13.50 to $750 a pill, begins a long-awaited securities fraud trial on June 26 in Brooklyn. Shkreli is being accused of running a Ponzi-like scheme between…

